NBC News highlighted a case study published by the University of Cincinnati's Susan McElroy, MD, and colleagues
Due to the fact that GLP-1 acting drugs such as dulaglutide, liraglutide, and semaglutide do not need dosage adjustments for patients with renal impairment, these medications are considered to be the most recommended choices for patients who have chronic kidney disease (Zheng et al
Hepatitis, elevated liver enzymes/jaundice
Ozempic isnt FDA-approved for PMOS, but some providers prescribe it off-label for potential benefits
In January 2025, the FDA updated Ozempic's warning label to include severe pancreatitis and acute kidney injury
Luteinizing Hormone Support With LH treatments through The Edge, we can boost your testosterone levels naturally by stimulating sperm production and accentuating your bodys normal male characteristics